Brief: Mustang Bio Reports Third Quarter 2020 Financial Results And Recent Corporate Highlights
Nov 6 (Reuters) - Mustang Bio Inc MBIO.O :
* MUSTANG BIO REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
AND
RECENT CORPORATE HIGHLIGHTS
* Q3 LOSS PER SHARE $0.23
* Q3 EARNINGS PER SHARE ESTIMATE $-0.25 -- REFINITIV IBES
DATA
* AS OF SEPTEMBER 30, 2020, COMPANY'S CASH, CASH EQUIVALENTS
AND
RESTRICTED CASH TOTALED $76.3 MILLION
Source text for Eikon: ID:nGNXbZMJBJ
Further company coverage: MBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mustang Bio
See all newsAdvisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
U.S. STOCKS ON THE MOVE-Dow, Phibro, Mustang Bio
Mustang soars on FDA's orphan drug tag for brain cancer therapy
Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Mustang Bio Inc - Enters Sale And Surrender Agreement With Abbvie